Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share.
|Articles|March 7, 2013
Diabetes Costs Nation $245 Billion Annually, Study Says
Advertisement
The growing toll of diabetes cost the nation a record high $245 billion in 2012, a 41% increase from $174 billion in 2007, according to new research released today.
The study Economic Costs of Diabetes in the U.S. in 2012, commissioned by the American Diabetes Association, estimated the health care and work-related costs of diagnosed diabetes. The full study will be published in the April issue of Diabetes Care.
Read the full story:
Source: USA Today
Advertisement
Related to this article
Three experts apply policy, pharmacy operations, and member-level lenses to the same prescriptions to show why cost at the counter decides adherence.
Most Medicaid unwinding losses were procedural. mPulse's SriVani Ganti explains how plans can keep eligible members.
KFF finds 4.3 million Medicare beneficiaries will lose their MA or stand-alone Part D plans at the end of 2026, as PDP options keep shrinking.
The new NCCN Guidelines for Patients: Caregiving for People With Cancer address finances, legal concerns, and household tasks alongside medical management, areas that an expert involved in their development says “often leave people reeling.”
Unclear ownership often leaves survivors without support, and coverage of social and psychological services could close the gap, says Bhatnagar.
About one quarter of patients with overactive bladder were taking their initial oral regimen at nearly 3 years, yet most reported symptom improvement.
Claims data show evidence of HIV virus in 5 of 2913 long-acting cabotegravir users and higher adherence vs oral therapy.
Advertisement
Advertisement
Trending on AJMC
1
At the Pharmacy, Affordability Connects Policy, Plans, and Patients
2
Olanzapine/Samidorphan Tied to Longer Persistence in Schizophrenia
3
UAB Works to Deliver Cutting-Edge Cancer Therapies, Reach Every Patient
4
The DTC GLP-1 Boom Solved Access. Can It Solve Adherence?
5